Ignite Creation Date:
2025-12-26 @ 4:01 PM
Ignite Modification Date:
2025-12-29 @ 4:51 AM
Study NCT ID:
NCT05191706
Status:
RECRUITING
Last Update Posted:
2025-04-03
First Post:
2021-12-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluate the Safety of DEXYCU for the Treatment of Inflammation Following Ocular Surgery for Childhood Cataract
Sponsor:
EyePoint Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-01-04
Start Date Type:
ACTUAL
Primary Completion Date:
2026-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-02
Completion Date Type:
ESTIMATED
First Submit Date:
2021-12-13
First Submit QC Date:
None
Study First Post Date:
2022-01-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-01
Last Update Post Date:
2025-04-03
Last Update Post Date Type:
ACTUAL